Neurological cancer clinical trials - [STAGING] Peter MacCallum Cancer Centre

If you would like to be considered for a clinical trial you will require a referral from your current treating team. Visit the Joining a clinical trial page for referral information.

For more information on neurological cancer trials, get in contact with our Monc A team This email address is being protected from spambots. You need JavaScript enabled to view it..

Open and Recruiting Clinical Trials

BrainPOP Precision

Evaluating the feasibility and impact of the implementation of precision medicine into the care of patients with brain cancers

Trial ID

ACTRN12624000884505

Cancer type

Brain cancers (central nervous system cancer, glioblastoma)

Status

Open and recruiting

Who can participate

Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial.

For full inclusion / exclusion criteria refer to the Australian Cancer Clinical Trial Registry.

GBM AGILE

GCAR-7213 / GBM AGILE

Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM

Trial ID

NCT03970447

Cancer type

Glioblastoma

Status

Open and recruiting

Phase

Phase two / three: A phase two / three clinical trial follows a phase one / two, in a larger group of patients with specific cancer types. The aim of a phase two / three is to compare the new treatment to existing treatments available for that cancer type and closely monitor patients to make sure the treatment is safe and effective in that cancer type.

Who can participate

Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial.

For full inclusion / exclusion criteria refer to the Australian Clinical Trials Registry.

LUMOS2

COGNO2201 / LUMOS2

Low and Anaplastic Grade Glioma Umbrella Study of Molecular Guided TherapieS

Trial ID

ACTRN12623000096651

Cancer type

Glioma

Status

Open and recruiting

Phase

Phase Two: A phase two clinical trial follows a phase one, in a large group of patients with selected cancer types. The aim of a phase two is to find out if the new treatment is effective in these cancer types.

Who can participate

Clinical trials can have restrictive criteria of who can and can’t participate, talk to your doctor if you are interested in this clinical trial.

For full inclusion / exclusion criteria refer to the Australian Clinical Trials Registry.

If you don’t find what you are looking for or would like a center closer to home that may also provide similar clinical trials, refer to the Victorian Cancer Trials Link or Australian Clinical Trials Registry.